These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 29508402)
1. Factors associated with a second deferral among donors eligible for re-entry after a false-positive screening test for syphilis, HCV, HBV and HIV. Grégoire Y; Germain M; Delage G Vox Sang; 2018 May; 113(4):339-344. PubMed ID: 29508402 [TBL] [Abstract][Full Text] [Related]
2. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers. Cable R; Musavi F; Notari E; Zou S; Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796 [TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors. Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328 [TBL] [Abstract][Full Text] [Related]
4. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526 [TBL] [Abstract][Full Text] [Related]
5. Causes of pre and post-donation deferrals among blood donors, at Kwale Satellite Blood Transfusion Center, Kwale County, Kenya, 2018-2022. Nyamu GW; Shee MA; Kiende P; Muthiani BM; Nakazea RJ; Mwasowa NM; Odhiambo F; King'oo JM; Wigina RN BMC Public Health; 2024 Aug; 24(1):2197. PubMed ID: 39138457 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of positive and false-positive results in syphilis screening of blood donors in Rio de Janeiro, Brazil. Sandes VS; Silva SGC; Motta IJF; Velarde LGC; de Castilho SR Transfus Med; 2017 Jun; 27(3):200-206. PubMed ID: 28230309 [TBL] [Abstract][Full Text] [Related]
8. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Van der Bij AK; Coutinho RA; Van der Poel CL Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629 [TBL] [Abstract][Full Text] [Related]
9. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011. Mohammadali F; Pourfathollah AA Arch Iran Med; 2014 Sep; 17(9):613-20. PubMed ID: 25204477 [TBL] [Abstract][Full Text] [Related]
10. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience. Vučetić D; Kecman G; Ilić V; Balint B Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495 [TBL] [Abstract][Full Text] [Related]
11. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors. Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711 [TBL] [Abstract][Full Text] [Related]
12. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Diarra A; Kouriba B; Baby M; Murphy E; Lefrere JJ Transfus Clin Biol; 2009; 16(5-6):444-7. PubMed ID: 19896404 [TBL] [Abstract][Full Text] [Related]
13. A novel strategy for screening blood donors for syphilis at Komfo Anokye Teaching Hospital, Ghana. Sarkodie F; Ullum H; Owusu-Dabo E; Owusu-Ofori S; Owusu-Ofori A; Hassall O Transfus Med; 2016 Feb; 26(1):63-6. PubMed ID: 26834072 [TBL] [Abstract][Full Text] [Related]
14. High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply. Candotti D; Sauvage V; Cappy P; Boullahi MA; Bizimana P; Mbensa GO; Oumar Coulibaly S; Rakoto Alson AO; Soumana H; Tagny-Tayou C; Murphy EL; Laperche S; Transfusion; 2020 Jan; 60(1):106-116. PubMed ID: 31777096 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of blood donors questionnaire in a developing country: The case of Gabon. Kouegnigan Rerambiah L; Biyoghe AS; Bengone C; Djoba Siawaya JF Transfus Clin Biol; 2014 Jun; 21(3):116-9. PubMed ID: 24811564 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence and determinants of transfusion transmissible infections among voluntary blood donors in Homabay, Kisumu and Siaya counties in western Kenya. Onyango CG; Ogonda L; Guyah B; Okoth P; Shiluli C; Humwa F; Opollo V BMC Res Notes; 2018 Mar; 11(1):171. PubMed ID: 29530086 [TBL] [Abstract][Full Text] [Related]
17. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161 [TBL] [Abstract][Full Text] [Related]
18. [Safe blood in the absence of viral infections due to HBV, HCV and HIV in serological window period in donors]. Contreras AM; Reta CB; Torres O; Celis A; Domínguez J Salud Publica Mex; 2011; 53 Suppl 1():S13-8. PubMed ID: 21877067 [TBL] [Abstract][Full Text] [Related]
19. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing. Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750 [TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study. Mohammed Y; Bekele A BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]